Strategy in managing anticoagulation therapy following prosthetic heart valve replacement in a patient with dengue fever.
Division of Infectious Diseases, National University Health System, 5 Lower Kent Ridge Road, 119074, Singapore. Electronic address: lionel_lum@nuhs.edu.sg.
Lionel Hon Wai
LH
Lum
Institute of Infectious Diseases and Epidemiology, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, 308433, Singapore. Electronic address: monica_chan@ttsh.com.sg.
Monica
M
Chan
Yong Loo Lin School of Medicine, National University Singapore, Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, Saw Swee Hock School of Public Health, National University Singapore, Singapore. Electronic address: yee_sin_leo@ttsh.com.sg.
Yee Sin
YS
Leo
D000368:Aged; D000925:Anticoagulants / Q000008:administration & dosage*; D003715:Dengue / Q000097:blood / Q000503:physiopathology*; D019918:Heart Valve Prosthesis Implantation; D006351:Heart Valves / Q000601:surgery*; D006470:Hemorrhage / Q000097:blood / Q000517:prevention & control; D006801:Humans; D019934:International Normalized Ratio; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D013927:Thrombosis / Q000097:blood / Q000517:prevention & control; D017361:Viral Nonstructural Proteins / Q000302:isolation & purification; D014859:Warfarin / Q000008:administration & dosage*
D000925:Anticoagulants; C000601110:NS4A protein, Dengue virus; D017361:Viral Nonstructural Proteins; D014859:Warfarin
Anticoagulation therapy; Bleeding; Dengue fever; Prosthetic heart valve; Valvular thrombosis